These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4574055)

  • 1. BCNU (NSC-409962) in the treatment of bronchogenic carcinoma.
    Whittington RM; Fairly JL; Majima H; Patno ME; Prentice R
    Cancer Chemother Rep; 1972 Dec; 56(6):739-43. PubMed ID: 4574055
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary report on the treatment of nonresectable cancer of the lung.
    Kaung DT; Wolf J; Hyde L; Zelen M
    Cancer Chemother Rep; 1974; 58(3):359-64. PubMed ID: 4276322
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiotherapy for bronchogenic carcinoma: actual difficulties and plans for the future.
    Dana M
    Cancer Chemother Rep 3; 1973 Mar; 4(2):153-5. PubMed ID: 4734076
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
    Takita H; Brugarolas A; Mittelman A; Vincent R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
    Curtis JE
    Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
    [No Abstract]   [Full Text] [Related]  

  • 6. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
    Stolinsky DC; Bull FE; Pajak TF; Bateman JR
    Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
    Alberto P; Barrelet L; Chapuis B; Garcia B
    Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of CCNU (NSC-79037) on bronchogenic carcinoma.
    Takita H; Brugarolas A
    J Natl Cancer Inst; 1973 Jan; 50(1):49-53. PubMed ID: 4348225
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
    Host H
    Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
    [No Abstract]   [Full Text] [Related]  

  • 10. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
    Walker MD; Hurwitz BS
    Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
    [No Abstract]   [Full Text] [Related]  

  • 11. Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma.
    Hansen HH; Muggia FM; Andrews R; Selawry OS
    Cancer; 1972 Aug; 30(2):315-24. PubMed ID: 4559404
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study.
    Brugarolas A; Rivas A; Lacave AJ; Gonzalez-Palacois F; Froufe A
    Cancer Chemother Rep; 1975; 59(5):1025-6. PubMed ID: 1106844
    [No Abstract]   [Full Text] [Related]  

  • 13. New agents and combinations in the treatment of bronchogenic carcinoma.
    Bodey GP; Gottlieb JA; Livingston R; Frei E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
    Perevodchikova NI; Bychkov MB
    Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of cyclophosphamide (NSC-26271) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of patients with inoperable or disseminated lung cancer.
    Ahmann DL; Carr DT; Coles DT; Hahn RG
    Cancer Chemother Rep; 1972 Jun; 56(3):401-3. PubMed ID: 19051501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some thoughts on surgical adjuvant studies in lung cancer.
    Carter SK
    Cancer Chemother Rep 3; 1973 Mar; 4(2):109-17. PubMed ID: 4729314
    [No Abstract]   [Full Text] [Related]  

  • 17. Superior vena caval obstruction due to small-cell anaplastic lung carcinoma. Response to chemotherapy.
    Kane RC; Cohen MH
    JAMA; 1976 Apr; 235(16):1717-8. PubMed ID: 176480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large cell bronchogenic carcinoma. Prolonged disease-free survival following chemotherapy.
    Vosika GJ
    JAMA; 1979 Feb; 241(6):594-5. PubMed ID: 216823
    [No Abstract]   [Full Text] [Related]  

  • 19. New drugs on the horizon in bronchogenic carcinoma.
    Carter SK
    Cancer; 1972 Nov; 30(5):1402-9. PubMed ID: 4117256
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitrosourea combinations in lung cancer.
    Livingston RB
    Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.